The charity has provided the ICR with funds to acquire laboratory reagents and equipment that will be used to work on research associated with the launch of a new clinical trial for rhabdomyosarcoma that is due to launch in hospitals such as GOSH and the Royal Marsden in 2018.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.